August 11, 2026, (Inside AI) — Chinese robot maker Unitree has triggered an unprecedented retail investor frenzy for its $900 million Shanghai initial public offering. The deal was oversubscribed by a staggering 8,000 times, according to an August 10 filing.
Retail investors bid for over 53 million shares, dwarfing the 6.5 million shares initially allocated. The overwhelming demand forced Unitree to boost the retail tranche to 9.7 million shares, or about 24% of the total offering.
Unitree, formally known as Yushu Technology, priced its IPO at 150.80 yuan per share. That values the company at roughly 61 billion yuan ($9 billion). The firm is set to become China’s first onshore listed humanoid-robot maker.
The valuation represents about 100 times earnings based on expected first-half 2026 net profit of 236 million to 283 million yuan. Such a multiple was once unthinkable in China’s tightly managed onshore market, where regulators typically curb speculative excess.
Regulators Embrace Animal Spirits #
This IPO marks a sharp departure from the cautious oversight that has long defined China’s stock exchanges. Regulators appear to be loosening their grip, allowing animal spirits to drive valuations at a moment when AI and robotics hype is peaking.
The move aligns with Beijing’s broader push to dominate advanced technologies. Yet it raises questions about market stability. The last time Chinese regulators encouraged risk-taking was during the 2015 stock market bubble, which ended in a $5 trillion rout.
Global IPO markets have seen similar AI-driven frenzies. In 2024, Arm Holdings and Reddit both saw massive first-day pops. But Unitree’s 8,000x oversubscription dwarfs those events, signaling a unique blend of retail mania and state endorsement.
Unitree’s Tech and Market Position #
Unitree has gained international recognition for its agile quadruped and humanoid robots. Its H1 humanoid model can run at 3.3 meters per second and perform backflips, rivaling Boston Dynamics’ Atlas at a fraction of the cost.
The company competes with Xiaomi’s CyberOne and Tesla’s Optimus in the humanoid race. However, Unitree’s focus on affordable, mass-market robots gives it a distinct edge in China’s vast industrial and consumer sectors.
Analysts caution that humanoid robotics remains a nascent field with unclear commercial viability. Unitree’s revenue relies heavily on research institutions and early adopters, not yet on large-scale enterprise deployment.
The IPO’s success could embolden other Chinese AI and robotics firms to rush to market. Deep Robotics and Galbot are among those reportedly eyeing listings. A wave of richly valued but unprofitable tech IPOs could test the market’s appetite.
Retail investors, who dominate China’s onshore trading, are notoriously sentiment-driven. The 8,000x oversubscription suggests a fear of missing out rather than careful analysis. If Unitree’s shares stumble post-listing, the fallout could be severe.
Regulators have tools to cool speculation, such as increasing margin requirements or limiting price swings. But their apparent endorsement of the Unitree frenzy suggests they are willing to tolerate short-term volatility for long-term tech ambitions.
The offering also highlights China’s evolving IPO system. The registration-based regime, adopted in 2023, gives more power to market forces. Unitree’s listing on the Shanghai Stock Exchange’s STAR Market underscores the bourse’s role as a hub for cutting-edge tech.
Global investors are watching closely. If Unitree delivers strong post-IPO performance, it could attract more foreign capital to China’s robotics sector. Conversely, a bust might reinforce skepticism about state-guided markets.
Unitree’s prospectus notes that it expects first-half 2026 net profit to be between 236 million and 283 million yuan. That implies a full-year run rate of about 500 million yuan, making the 61 billion yuan valuation look stretched even by tech standards.
Still, the company’s backers include prominent venture capital firms like Sequoia Capital China and Hillhouse Capital. Their involvement lends credibility, though early investors may use the IPO to cash out partially.
As the first humanoid-robot maker to list onshore, Unitree will set a benchmark. Its trading debut, expected within weeks, will be a litmus test for China’s AI capital markets experiment.